Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Ryan

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 1, 1995
Clinical experience with acarbose: results of a Canadian multicentre studyN W Rodger, J L Chiasson, R G Josse, et al.
Diabetes Care|October 17, 1998
No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrateT M Wolever, J L Chiasson, R G Josse, et al.
Annals of Internal Medicine|December 15, 1994
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trialJ L Chiasson, R G Josse, J A Hunt, et al.
Journal of Medicinal Chemistry|May 1, 1981
A potent, new, sedative--hypnotic agent: 5,7-dihydro-5,5,7,7-tetramethyl-3-(3-nitrophenyl)furo[3,4-e]-as-triazine 4-oxideG B Bennett, R G Babington, M A Deacon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2007
High risk of sensitization after failed islet transplantationP M Campbell, P A Senior, A Salam, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1995
One-year acarbose treatment raises fasting serum acetate in diabetic patientsT M Wolever, R Radmard, J L Chiasson, et al.
The American Journal of Clinical Nutrition|June 1, 1994
Determinants of diet glycemic index calculated retrospectively from diet records of 342 individuals with non-insulin-dependent diabetes mellitusT M Wolever, P M Nguyen, J L Chiasson, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 9, 2012
Altering source or amount of dietary carbohydrate has acute and chronic effects on postprandial glucose and triglycerides in type 2 diabetes: Canadian trial of Carbohydrates in Diabetes (CCD)T M S Wolever, A L Gibbs, J-L Chiasson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 26, 2007
Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantationP M Campbell, A Salam, E A Ryan, et al.
Diabetes Care|August 11, 2000
Effect of acarbose on insulin sensitivity in elderly patients with diabetesG S Meneilly, E A Ryan, J Radziuk, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 1, 1995
Clinical experience with acarbose: results of a Canadian multicentre studyN W Rodger, J L Chiasson, R G Josse, et al.
Diabetes Care|October 17, 1998
No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrateT M Wolever, J L Chiasson, R G Josse, et al.
Annals of Internal Medicine|December 15, 1994
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trialJ L Chiasson, R G Josse, J A Hunt, et al.
Journal of Medicinal Chemistry|May 1, 1981
A potent, new, sedative--hypnotic agent: 5,7-dihydro-5,5,7,7-tetramethyl-3-(3-nitrophenyl)furo[3,4-e]-as-triazine 4-oxideG B Bennett, R G Babington, M A Deacon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2007
High risk of sensitization after failed islet transplantationP M Campbell, P A Senior, A Salam, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1995
One-year acarbose treatment raises fasting serum acetate in diabetic patientsT M Wolever, R Radmard, J L Chiasson, et al.
The American Journal of Clinical Nutrition|June 1, 1994
Determinants of diet glycemic index calculated retrospectively from diet records of 342 individuals with non-insulin-dependent diabetes mellitusT M Wolever, P M Nguyen, J L Chiasson, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 9, 2012
Altering source or amount of dietary carbohydrate has acute and chronic effects on postprandial glucose and triglycerides in type 2 diabetes: Canadian trial of Carbohydrates in Diabetes (CCD)T M S Wolever, A L Gibbs, J-L Chiasson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 26, 2007
Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantationP M Campbell, A Salam, E A Ryan, et al.
Diabetes Care|August 11, 2000
Effect of acarbose on insulin sensitivity in elderly patients with diabetesG S Meneilly, E A Ryan, J Radziuk, et al.
Pageof 11